130 related articles for article (PubMed ID: 6334323)
1. Proton relaxation enhancement in tissue due to ingested manganese chloride: time course and dose response in the rat.
Mamourian AC; Burnett KR; Goldstein EJ; Wolf GL; Kressel HY; Baum S
Physiol Chem Phys Med NMR; 1984; 16(2):123-8. PubMed ID: 6334323
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit.
Wolf GL; Baum L
AJR Am J Roentgenol; 1983 Jul; 141(1):193-7. PubMed ID: 6305179
[TBL] [Abstract][Full Text] [Related]
3. Studies of tissue NMR relaxation enhancement by manganese. Dose and time dependences.
Kang YS; Gore JC
Invest Radiol; 1984; 19(5):399-407. PubMed ID: 6511248
[TBL] [Abstract][Full Text] [Related]
4. Effect of manganese on human placental spin-lattice (T1) and spin-spin (T2) relaxation times.
Angtuaco TL; Mattison DR; Thomford PJ; Jordan J
Physiol Chem Phys Med NMR; 1986; 18(1):41-8. PubMed ID: 3022315
[TBL] [Abstract][Full Text] [Related]
5. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
Hoehn-Berlage M; Bockhorst K
Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
[TBL] [Abstract][Full Text] [Related]
6. The oral administration of MnCl2: a potential alternative to IV injection for tissue contrast enhancement in magnetic resonance imaging.
Burnett KR; Goldstein EJ; Wolf GL; Sen S; Mamourian AC
Magn Reson Imaging; 1984; 2(4):307-14. PubMed ID: 6530933
[TBL] [Abstract][Full Text] [Related]
7. Paramagnetic macrocyclic complexes as contrast agents for MR imaging: proton nuclear relaxation rate enhancement in aqueous solution and in rat tissues.
Jackels SC; Kroos BR; Hinson WH; Karstaedt N; Moran PR
Radiology; 1986 May; 159(2):525-30. PubMed ID: 3961187
[TBL] [Abstract][Full Text] [Related]
8. Effects of manganese (Mn++) and iron (Fe+++) on magnetic resonance imaging (MRI) characteristics of human placenta and amniotic fluid.
Plowchalk DR; Jordan JP; Thomford PJ; Mattison DR
Physiol Chem Phys Med NMR; 1987; 19(1):35-41. PubMed ID: 3615643
[TBL] [Abstract][Full Text] [Related]
9. Manganese-based oral contrast agent for liver magnetic resonance imaging: evaluation of the time course and dose response of liver signal intensity enhancement.
Rief M; Huppertz A; Asbach P; Franiel T; Schwenke C; Hamm B; Taupitz M; Wagner M
Invest Radiol; 2010 Sep; 45(9):565-71. PubMed ID: 20644484
[TBL] [Abstract][Full Text] [Related]
10. Orally administered manganese chloride: enhanced detection of hepatic tumors in rats.
Kreft BP; Baba Y; Tanimoto A; Finn JP; Stark DD
Radiology; 1993 Feb; 186(2):543-8. PubMed ID: 8421762
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase activities in liver, heart, spleen and kidney of the rat. Organ-specific changes in aging and after chronic manganese chloride administration.
Lai JC; Leung TK; Lim L
Exp Gerontol; 1982; 17(3):219-25. PubMed ID: 7140863
[No Abstract] [Full Text] [Related]
12. Use of a paramagnetic substance, colloidal manganese sulfide, as an NMR contrast material in rats.
Chilton HM; Jackels SC; Hinson WH; Ekstrand KE
J Nucl Med; 1984 May; 25(5):604-7. PubMed ID: 6726439
[TBL] [Abstract][Full Text] [Related]
13. Low paramagnetic-ion content in cancer cells: its significance in cancer detection by magnetic resonance imaging.
Ling GN; Kolebic T; Damadian R
Physiol Chem Phys Med NMR; 1990; 22(1):1-14. PubMed ID: 2084708
[TBL] [Abstract][Full Text] [Related]
14. Ingested manganese chloride as a contrast agent for magnetic resonance imaging.
Cory DA; Schwartzentruber DJ; Mock BH
Magn Reson Imaging; 1987; 5(1):65-70. PubMed ID: 3586874
[TBL] [Abstract][Full Text] [Related]
15. Manganese protoporphyrin IX. A potential intravenous paramagnetic NMR contrast agent: preliminary communication.
Jackson LS; Nelson JA; Case TA; Burnham BF
Invest Radiol; 1985; 20(2):226-9. PubMed ID: 3988477
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific manganese toxicity: a comparative in vitro study on five cellular models exposed to MnCl(2).
Rovetta F; Catalani S; Steimberg N; Boniotti J; Gilberti ME; Mariggiò MA; Mazzoleni G
Toxicol In Vitro; 2007 Mar; 21(2):284-92. PubMed ID: 17055213
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary clearance of soluble and insoluble forms of manganese.
Drown DB; Oberg SG; Sharma RP
J Toxicol Environ Health; 1986; 17(2-3):201-12. PubMed ID: 3959109
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
19. T1 efficacy of EVP-ABD: a potential manganese-based MR contrast agent for hepatic vascular and tissue phase imaging.
Zuo CS; Seoane P; Lanigan T; Harnish P; Prasad PV; Storey P; Li W; Rofsky NM
J Magn Reson Imaging; 2002 Dec; 16(6):668-75. PubMed ID: 12451580
[TBL] [Abstract][Full Text] [Related]
20. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
Leveille-Webster CR; Rogers J; Arias IM
Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
